Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?

被引:43
作者
Arboleda, John F. [1 ,2 ]
Urcuqui-Inchima, Silvio [1 ]
机构
[1] Univ Antioquia, Fac Med, Grp Immunovirol, Medellin, Colombia
[2] Comfama, Behav Sci & Hlth Care Habits Unit, Medellin, Colombia
关键词
SARS-Cov-2; COVID-19; vitamin D; antiviral; anti-inflammatory; INFLUENZA-A; INFECTION; ACE2; D-3; RECEPTOR; PEPTIDE; HEALTH; VIRUS; TRIAL; LL-37;
D O I
10.3389/fimmu.2020.01523
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
[No abstract available]
引用
收藏
页数:4
相关论文
共 64 条
[2]
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies [J].
Ahmed, Syed Faraz ;
Quadeer, Ahmed A. ;
McKay, Matthew R. .
VIRUSES-BASEL, 2020, 12 (03)
[3]
Ajabshir Sahar, 2014, J Nephropathol, V3, P41, DOI 10.12860/jnp.2014.09
[4]
Alipio M., 2020, VITAMIN D SUPPLEMENT, V2019, P1, DOI [DOI 10.2139/SSRN.3571484, 10.2139/ssrn.3571484]
[5]
Human macrophages differentiated in the presence of vitamin D3 restrict dengue virus infection and innate responses by downregulating mannose receptor expression [J].
Alzate, John F. Arboleda ;
Rodenhuis-Zybert, Izabela A. ;
Hernandez, Juan C. ;
Smit, Jolanda M. ;
Urcuqui-Inchima, Silvio .
PLOS NEGLECTED TROPICAL DISEASES, 2017, 11 (10)
[6]
[Anonymous], 2020, LEAD COVID 19 TRIAL
[7]
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms [J].
Baig, Abdul Mannan ;
Khaleeq, Areeba ;
Ali, Usman ;
Syeda, Hira .
ACS CHEMICAL NEUROSCIENCE, 2020, 11 (07) :995-998
[8]
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy? [J].
Batlle, Daniel ;
Wysocki, Jan ;
Satchell, Karla .
CLINICAL SCIENCE, 2020, 134 (05) :543-545
[9]
Vitamin D and the anti-viral state [J].
Beard, Jeremy A. ;
Bearden, Allison ;
Striker, Rob .
JOURNAL OF CLINICAL VIROLOGY, 2011, 50 (03) :194-200
[10]
Bergman P, 2007, CURR HIV RES, V5, P410